MedNet Solutions Receives First Major Outside Financing

Article

Applied Clinical Trials

Funds to Accelerate iMedNet EDC Sales, Marketing and R&D Initiatives

MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, announced that Arrowroot Capital, a growth equity firm focused on software-as-a-service (SaaS) and Internet-based businesses, has made a $4 million investment in MedNet Solutions. This funding will be used to support the ongoing growth and development of both MedNet and iMedNet EDC, its flagship cloud-based eClinical technology platform.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.